Vifor Confident About Veltassa Despite AZ Rival
Hyperkalemia Therapy Now Has Competition From Lokelma
Executive Summary
The Swiss company has been talking up its therapy for elevated levels of potassium in the blood which contributed to strong sales growth for Vifor in 2019.